These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34913181)

  • 1. Brain TDP-43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss.
    Sainouchi M; Tada M; Fitrah YA; Hara N; Tanaka K; Idezuka J; Aida I; Nakajima T; Miyashita A; Akazawa K; Ikeuchi T; Onodera O; Kakita A
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12786. PubMed ID: 34913181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
    Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
    Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
    Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
    Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.
    Ling H; Gelpi E; Davey K; Jaunmuktane Z; Mok KY; Jabbari E; Simone R; R'Bibo L; Brandner S; Ellis MJ; Attems J; Mann D; Halliday GM; Al-Sarraj S; Hedreen J; Ironside JW; Kovacs GG; Kovari E; Love S; Vonsattel JPG; Allinson KSJ; Hansen D; Bradshaw T; Setó-Salvia N; Wray S; de Silva R; Morris HR; Warner TT; Hardy J; Holton JL; Revesz T
    Acta Neuropathol; 2020 Apr; 139(4):717-734. PubMed ID: 31950334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance and limitation of the pathological classification of TDP-43 proteinopathy.
    Arai T
    Neuropathology; 2014 Dec; 34(6):578-88. PubMed ID: 25196969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology.
    Tando S; Kasai T; Mizuta I; Takahashi H; Yaoi T; Saito K; Hojo T; Mizuno T; Hasegawa M; Itoh K
    Neuropathology; 2021 Jun; 41(3):214-225. PubMed ID: 33537992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Related Pathology in Corticobasal Degeneration.
    Mimuro M; Iwasaki Y
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology.
    Nishihira Y; Tan CF; Hoshi Y; Iwanaga K; Yamada M; Kawachi I; Tsujihata M; Hozumi I; Morita T; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2009 Jan; 117(1):45-53. PubMed ID: 18923836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
    Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
    Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.
    Kouri N; Oshima K; Takahashi M; Murray ME; Ahmed Z; Parisi JE; Yen SH; Dickson DW
    Acta Neuropathol; 2013 May; 125(5):741-52. PubMed ID: 23371366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.
    Fujishiro H; Uchikado H; Arai T; Hasegawa M; Akiyama H; Yokota O; Tsuchiya K; Togo T; Iseki E; Hirayasu Y
    Acta Neuropathol; 2009 Feb; 117(2):151-8. PubMed ID: 19039597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
    Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
    Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.